Investment Analysts’ Weekly Ratings Changes for West Pharmaceutical Services (WST)

Several analysts have recently updated their ratings and price targets for West Pharmaceutical Services (NYSE: WST):

• 7/27/2026 – West Pharmaceutical Services had its “outperform” rating reaffirmed by Evercore Inc. They now have a $425.00 price target on the stock.
• 7/24/2026 – West Pharmaceutical Services had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 7/15/2026 – West Pharmaceutical Services had its “buy” rating reaffirmed by TD Cowen.
• 7/13/2026 – West Pharmaceutical Services is now covered by BNP Paribas Exane. They set an “outperform” rating and a $447.00 price target on the stock.
• 7/9/2026 – West Pharmaceutical Services had its price target raised by Morgan Stanley from $325.00 to $365.00. They now have an “equal weight” rating on the stock.
• 7/6/2026 – West Pharmaceutical Services had its “outperform” rating reaffirmed by Evercore Inc. They now have a $410.00 price target on the stock.
• 7/2/2026 – West Pharmaceutical Services had its price target raised by KeyCorp from $350.00 to $390.00. They now have an “overweight” rating on the stock.
• 6/9/2026 – West Pharmaceutical Services was upgraded by Barclays PLC from “equal weight” to “overweight”. They now have a $400.00 price target on the stock, up from $310.00.
• 6/2/2026 – West Pharmaceutical Services had its “overweight” rating reaffirmed by Stephens. They now have a $360.00 price target on the stock.
• 6/1/2026 – West Pharmaceutical Services is now covered by Wolfe Research. They set an “outperform” rating and a $375.00 price target on the stock.
• 6/1/2026 – West Pharmaceutical Services was upgraded by Wolfe Research to “outperform”. They now have a $375.00 price target on the stock.

West Pharmaceutical Services Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 5th. Stockholders of record on Wednesday, July 29th will be given a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Wednesday, July 29th. West Pharmaceutical Services’s dividend payout ratio (DPR) is 11.27%.

West Pharmaceutical Services, Inc is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.